207 related articles for article (PubMed ID: 18330899)
21. Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 gene.
De Rocco D; Pujol-Moix N; Pecci A; Faletra F; Bozzi V; Balduini CL; Savoia A
Eur J Med Genet; 2009; 52(4):191-4. PubMed ID: 19450438
[TBL] [Abstract][Full Text] [Related]
22. Identification of the first in cis mutations in MYH9 disorder.
Miyajima Y; Kunishima S
Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
[TBL] [Abstract][Full Text] [Related]
23. Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome).
Selleng K; Lubenow LE; Greinacher A; Warkentin TE
Eur J Haematol; 2007 Sep; 79(3):263-8. PubMed ID: 17655694
[TBL] [Abstract][Full Text] [Related]
24. Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancer.
Xia ZK; Yuan YC; Yin N; Yin BL; Tan ZP; Hu YR
Dis Esophagus; 2012 Jul; 25(5):427-36. PubMed ID: 21951916
[TBL] [Abstract][Full Text] [Related]
25. MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motility.
Hosono Y; Usukura J; Yamaguchi T; Yanagisawa K; Suzuki M; Takahashi T
Biochem Biophys Res Commun; 2012 Nov; 428(1):173-8. PubMed ID: 23068101
[TBL] [Abstract][Full Text] [Related]
26. Translational control mediated by hnRNP K links NMHC IIA to erythroid enucleation.
Naarmann-de Vries IS; Brendle A; Bähr-Ivacevic T; Benes V; Ostareck DH; Ostareck-Lederer A
J Cell Sci; 2016 Mar; 129(6):1141-54. PubMed ID: 26823606
[TBL] [Abstract][Full Text] [Related]
27. Conditional expression of a truncated fragment of nonmuscle myosin II-A alters cell shape but not cytokinesis in HeLa cells.
Wei Q; Adelstein RS
Mol Biol Cell; 2000 Oct; 11(10):3617-27. PubMed ID: 11029059
[TBL] [Abstract][Full Text] [Related]
28. Ablation and mutation of nonmuscle myosin heavy chain II-B results in a defect in cardiac myocyte cytokinesis.
Takeda K; Kishi H; Ma X; Yu ZX; Adelstein RS
Circ Res; 2003 Aug; 93(4):330-7. PubMed ID: 12893741
[TBL] [Abstract][Full Text] [Related]
29. Advances in the understanding of MYH9 disorders.
Kunishima S; Saito H
Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
[TBL] [Abstract][Full Text] [Related]
30. Expression of Myh9 in the mammalian cochlea: localization within the stereocilia.
Mhatre AN; Li Y; Atkin G; Maghnouj A; Lalwani AK
J Neurosci Res; 2006 Sep; 84(4):809-18. PubMed ID: 16862555
[TBL] [Abstract][Full Text] [Related]
31. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
[TBL] [Abstract][Full Text] [Related]
32. Nonmuscle Myosin Heavy Chain IIA Recognizes Sialic Acids on Sialylated RNA Viruses To Suppress Proinflammatory Responses via the DAP12-Syk Pathway.
Liu Y; Li R; Chen XX; Zhi Y; Deng R; Zhou EM; Qiao S; Zhang G
mBio; 2019 May; 10(3):. PubMed ID: 31064828
[TBL] [Abstract][Full Text] [Related]
33. Opposite effects of overexpressed myosin Va or heavy meromyosin Va on vesicle distribution, cytoskeleton organization, and cell motility in nonmuscle cells.
Eppinga RD; Peng IF; Lin JL; Wu CF; Lin JJ
Cell Motil Cytoskeleton; 2008 Mar; 65(3):197-215. PubMed ID: 18044718
[TBL] [Abstract][Full Text] [Related]
34. Identification of three in-frame deletion mutations in MYH9 disorders suggesting an important hot spot for small rearrangements in MYH9 exon 24.
Miyazaki K; Kunishima S; Fujii W; Higashihara M
Eur J Haematol; 2009 Sep; 83(3):230-4. PubMed ID: 19459928
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders.
Kunishima S; Hamaguchi M; Saito H
Blood; 2008 Mar; 111(6):3015-23. PubMed ID: 18192507
[TBL] [Abstract][Full Text] [Related]
36. Megalin and nonmuscle myosin heavy chain IIA interact with the adaptor protein Disabled-2 in proximal tubule cells.
Hosaka K; Takeda T; Iino N; Hosojima M; Sato H; Kaseda R; Yamamoto K; Kobayashi A; Gejyo F; Saito A
Kidney Int; 2009 Jun; 75(12):1308-1315. PubMed ID: 19340093
[TBL] [Abstract][Full Text] [Related]
37. High-resolution melting analysis for detection of MYH9 mutations.
Provaznikova D; Kumstyrova T; Kotlin R; Salaj P; Matoska V; Hrachovinova I; Rittich S
Platelets; 2008 Sep; 19(6):471-5. PubMed ID: 18925516
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders.
Kunishima S; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2008 Jun; 80(6):540-4. PubMed ID: 18284620
[TBL] [Abstract][Full Text] [Related]
39. Cleavage of nonmuscle myosin heavy chain-A during apoptosis in human Jurkat T cells.
Kato M; Fukuda H; Nonaka T; Imajoh-Ohmi S
J Biochem; 2005 Feb; 137(2):157-66. PubMed ID: 15749830
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of MYH9 mRNA at leukocyte inclusion bodies in MYH9 disorders.
Kunishima S; Hirano K; Hamaguchi M; Saito H
Eur J Haematol; 2008 Oct; 81(4):325-6. PubMed ID: 18616507
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
